title: [Thrombopenia and thrombosis under heparin treatment. Need for aggregation tests before treatment with low molecular weight heparin].
authors.forename: Y
authors.initials: Y
authors.lastname: Gruel
authors.forename: J
authors.initials: J
authors.lastname: Leroy
authors.forename: C
authors.initials: C
authors.lastname: Guerois
authors.forename: B
authors.initials: B
authors.lastname: Delahousse
authors.forename: T
authors.initials: T
authors.lastname: Briand
authors.forename: D
authors.initials: D
authors.lastname: Cibois
authors.forename: D
authors.initials: D
authors.lastname: Trouslard
mesh_terms: D000368:Aged; D006493:Heparin / Q000009:adverse effects*; D006801:Humans; D008297:Male; D010974:Platelet Aggregation / Q000187:drug effects*; D013921:Thrombocytopenia / Q000139:chemically induced*; D013927:Thrombosis / Q000139:chemically induced*
chemical_list: D006493:Heparin
vernacular_title: Thrombopénie et thrombose sous héparine. Nécessité des tests d'agregation avant le traitement par l'héparine de bas poids moléculaire.